Cerebrospinal fluid (CSF) analyses in HIV-1 primary neurological disease
Author
dc.contributor.author
Nogales-Gaete, J.
Author
dc.contributor.author
Syndulko, K.
Author
dc.contributor.author
Tourtellotte, W. W.
Admission date
dc.date.accessioned
2019-01-29T14:51:17Z
Available date
dc.date.available
2019-01-29T14:51:17Z
Publication date
dc.date.issued
1992
Cita de ítem
dc.identifier.citation
The Italian Journal of Neurological Sciences, Volumen 13, Issue 8, 2018, Pages 667-683
Identifier
dc.identifier.issn
03920461
Identifier
dc.identifier.issn
15903478
Identifier
dc.identifier.other
10.1007/BF02334971
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/160976
Abstract
dc.description.abstract
This paper will focus on CSF findings in HIV-1 Neurological Disease (ND). Why use CSF as exploration window of the HIV-CNS involvement? Traditionally, CSF analysis has been an effective diagnostic method as well as a means of monitoring treatment in several infectious and immune pathologies of the CNS. Consequently there is an abundance of mature background information [113, 145, 147] particularly in terms of detecting infectious agents, using IgG findings as immunological indexes, and utilizing CSF findings to map the evolution of ND. We will explore the papers that utilize CSF variables as dependent measures to explore the effects of HIV disease, particularly HIV ND, cited in Index Medicus and MEDLINE data base, and published in Spanish, Italian and English, between 1985 to 1991. We will restrict out review to those studies that exclude HIV cases with CNS opportunistic infections or neoplasms, and thus focus on what the CSF can tell us about the primary effects of HIV on the brain as